It made the call for anyone suffering from a 'severe reaction' to GLP-1 medicine. According to the Government website, glucagon-like peptide-1 receptor agonists (GLP-1s) are medicines that help people ...

Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...

Three popular GLP-1 receptor agonists carried similar risks for serious gastrointestinal (GI) events among adults with type 2 ...

Meanwhile, beta blocker medications tend to reduce REM sleep, which is when most dreaming occurs, but research has found that ...

Seeking Alpha's roundup of statements, announcements, and remarks that could impact markets, sectors, or individual stocks. Read more here.

"Every day, I got on the scales and I still weighed exactly the same as before," Leith, 85, told U.K. paper 'The Times' ...

The British TV star Jeremy Clarkson said he had an unexpected blunder while at airport security as a result of taking Mounjaro.

Viking Therapeutics delivered a disappointing earnings report on October 22, revealing a quarterly loss of $0.81 per share that fell substantially short of ...

El ensayo clínico, que busca reclutar a 1000 pacientes con COVID persistente en todo el país, explorará cómo la autoadministración de tirzepatida, el agonista del GLP-1 de Eli Lilly comercializado ...

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.

Groundbreaking diabetes and weight loss drugs like Ozempic and Mounjaro are transforming treatment, offering significant ...

Groundbreaking GLP-1 drugs like Ozempic, Mounjaro and Wegovy are revolutionising weight loss, with studies showing ...